Coffee consumption and mortality in Japan with 18 years of follow-up: the Jichi Medical School Cohort Study.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 19 05 2020
revised: 08 10 2020
accepted: 29 10 2020
pubmed: 22 1 2021
medline: 17 3 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

Coffee consumption can be expected to reduce mortality due to cardiovascular diseases and cancer. This study tested the hypothesis of an inverse association between coffee intake and all-cause mortality and mortality due to cancer, coronary heart disease, or stroke. Prospective cohort study. We analyzed data from the Jichi Medical School Cohort Study, Japan, enrolling 9946 subjects (men/women: 3870/6,076, age: 19-93 years) from 12 communities. A food frequency questionnaire assessing the subjects' daily coffee consumption was used. During an average follow-up of 18.4 years, the total number of deaths was 2024, including 677 for cancer, 238 for coronary heart disease, and 244 for stroke. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of all-cause mortality and cause-specific mortality due to cancer, coronary heart disease, and stroke. Overall, no significant association was shown between coffee consumption and all-cause mortality. In the cause-specific mortality analyses, stroke mortality was significantly lower in those who consumed 1-2 cups of coffee daily (HR [95% CI]: 0.63 [0.42-0.95]) than in those who do not consume coffee, and this association occurred only in men. This study showed no significant association between coffee consumption and all-cause mortality. A U-shaped association between coffee consumption and stroke mortality with a 37% lower stroke mortality, only significant in men who consume 1-2 cups of coffee daily was observed. It is necessary to examine the possibility of intervention studies to reduce stroke mortality through coffee consumption.

Identifiants

pubmed: 33476939
pii: S0033-3506(20)30477-7
doi: 10.1016/j.puhe.2020.10.021
pii:
doi:

Substances chimiques

Coffee 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-30

Informations de copyright

Copyright © 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Auteurs

T Sakamaki (T)

Graduate School of Saitama Prefectural University, Saitama, Japan.

K Kayaba (K)

Graduate School of Saitama Prefectural University, Saitama, Japan.

K Kotani (K)

Division of Community and Family Medicine, Center for Community Medicine, Jichi Medical University, Tochigi, Japan.

M Namekawa (M)

Graduate School of Saitama Prefectural University, Saitama, Japan.

T Hamaguchi (T)

Graduate School of Saitama Prefectural University, Saitama, Japan.

N Nakaya (N)

Graduate School of Saitama Prefectural University, Saitama, Japan. Electronic address: nakaya-naoki@spu.ac.jp.

S Ishikawa (S)

Medical Education Center, Jichi Medical University, Tochigi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH